arrow
Z

Zien Zhou

university of new south wales sydney
H指数:21
被引数:1,989

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimal Definition of Early Neurological Deterioration in Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED Study

溶栓治疗的急性缺血性卒中早期神经功能恶化的最优定义:ENCHANTED研究

2026-01-010
PRE
Two-year outcomes of quantitative flow ratio-based physiology-guided percutaneous coronary intervention in patients with low-risk acute coronary syndrome: a prespecified secondary analysis of FAVOR III China

基于定量血流比率的生理学指导经皮冠状动脉介入治疗在低危急性冠状动脉综合征患者中的两年结局:FAVOR III China的预先设定的二次分析

2025-08-300
PREAI
Twenty-Four-Hour Post-Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study

急性缺血性脑卒中溶栓治疗后24小时NIHSS评分是预后最强的预测指标:ENCHANTED研究

2024-09-173
OAAI
Covert Cerebrovascular Changes in People With Heart Disease
2024-04-230
PRE
Thrombolysis outcomes according to arterial characteristics of acute ischemic stroke by alteplase dose and blood pressure target
2021-06-241
OAAI
Low Dose versus Standard Dose Alteplase in Acute Lacunar Ischemic Stroke.
STROKE
IF8.9
2021-03-010
OA
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria A CREDENCE Secondary Analysis
2021-02-2243
OA
Sodium-glucose co-transporter-2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta-analysis

2型糖尿病患者钠-葡萄糖co-transporter-2抑制与眼部预后的系统评价和荟萃分析

2020-10-1319
OAAI
Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial
2020-04-24121
OAAI